HK Stock Market Move | JINGCHENG MAC (00187) increased by over 5%, affiliated with Beijing Bawei to support the world's first tower-type solar thermal replacement project for ultra-heavy oil extraction being put into operation.
Beijing Jingcheng Machinery Electric Company (00187) rose more than 5%, rallying to 6.27 HKD at one point during trading. As of the time of writing, it has risen 8.28% to 5.23 HKD, with a trading volume of 446 million HKD.
JINGCHENG MAC (00187) rose more than 5%, reaching as high as HK$6.27 during trading. As of the time of writing, it had risen by 8.28% to HK$5.23, with a turnover of HK$446 million.
On the news front, according to the WeChat public platform "Jingcheng Electromechanical", on September 12th, the world's first tower-type solar thermal substitution project for ultra-heavy oil extraction was put into operation in the Fengcheng Oilfield in Xinjiang, marking a major breakthrough for China in the field of solar thermal technology and environmentally-friendly development of heavy oil. Jingcheng Electromechanical, a subsidiary of Beijing Baoyi, as the overall solution provider for key equipment of the project, successfully developed and designed the core equipment installed on the top of the absorber tower - the high-temperature water-gas heat absorber, providing solid guarantee for the project to achieve the design targets smoothly and stably.
Under the resonance of the "dual carbon" strategy and the wave of intelligent manufacturing, Jingcheng Electromechanical is expanding from traditional manufacturing equipment to emerging industries such as hydrogen energy, digital hydraulics, and Siasun Robot&Automation. Sinolink believes that 2025 is the settlement point for the medium and long-term planning of hydrogen energy, and the hydrogen energy and fuel cell industry will enter a period of rapid expansion. The landing of fuel cell vehicles and green hydrogen projects will accelerate, with hydrogen energy and fuel cell manufacturing being the two main themes. It is recommended to continue to pay attention to them.
Related Articles

Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.

SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.

Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.

SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.

Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
